Stem Cell-Derived Neuron Maturation via Splicing Factor Reprogramming
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current protocols for differentiating pluripotent stem cells into neurons result in embryonic neurons that fail to mature in vitro, limiting the study of late-onset neurodegenerative diseases as they do not reflect adult neuronal biology.
Innovation Solution
Overexpressing Mbnl2 and optionally Rbfox1, and reducing PTBP1/2 expression in pluripotent stem cells or neurons to accelerate maturation, using lentivirus constructs and conditional expression systems to drive adult splicing programs.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If current differentiation protocols are used, then neurons can be generated from pluripotent stem cells, but the neurons remain at an embryonic identity and fail to mature in vitro
Solution Approach 1:
The invention changes the molecular parameters of the differentiation system by introducing specific transcription factors (Mbnl2, Rbfox1, PTBP1/2) to shift the neuronal developmental state from embryonic to mature. This involves modulating gene expression levels and alternative splicing patterns to achieve maturation without extending culture time
Solution Approach 2:
The invention applies preliminary molecular interventions during the differentiation process to pre-program mature neuronal characteristics. By introducing maturation factors at specific stages, the neurons are guided toward a mature state before completing full differentiation, effectively skipping the prolonged embryonic phase
2Duration of action of stationary object
If culture time is extended to promote maturation, then neurons may reach adult identity, but this is not achieved with current protocols and limits study of late-onset diseases
Solution Approach 1:
The invention changes the temporal parameter of neuronal development by accelerating the maturation timeline through molecular intervention. Instead of extending culture duration, specific gene expression parameters are modified to speed up the developmental process, achieving mature neuronal phenotypes in a shortened timeframe
Solution Approach 2:
The invention introduces intermediary molecules (transcription factors and splicing regulators) that mediate the transition from embryonic to mature neuronal state. These intermediaries act as catalysts to bridge the developmental gap without requiring prolonged culture periods
3Loss of information
If molecular mechanisms of neuronal maturation are not understood, then stem cell-based models cannot effectively interrogate late-onset diseases
Solution Approach 1:
The invention implements a feedback mechanism where the effects of introducing specific transcription factors are monitored and used to refine the differentiation protocol. By observing which molecular interventions successfully induce maturation, the protocol is optimized to systematically advance understanding of maturation mechanisms while improving disease modeling capability
Data Source
AI summary
Methods for generating mature neurons differentiated from pluripotent stem cells, such as to facilitate the study of late-onset neurodegenerative disease, are disclosed. The methods include overexpressing the splicing factor muscleblind like splicing regulator 2 (Mbnl2) in cortical neurons. In some aspects, the method further comprises overexpressing RNA binding fox-1 homolog 1 (Rbfox1) and/or reducing expression of polypyrimidine tract binding proteins PTBP1/2. The methods also include accelerated derivation of mature neuron and generation of a tau pathology model. Also disclosed are constructs and compositions for accelerated derivation of mature neuron and/or generation of a tau pathology model.